Inspire Medical Systems Share Holder Equity 2017-2024 | INSP

Inspire Medical Systems share holder equity from 2017 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • Inspire Medical Systems share holder equity for the quarter ending September 30, 2024 was $0.697B, a 28% increase year-over-year.
  • Inspire Medical Systems share holder equity for 2023 was $0.573B, a 15.42% increase from 2022.
  • Inspire Medical Systems share holder equity for 2022 was $0.496B, a 116.55% increase from 2021.
  • Inspire Medical Systems share holder equity for 2021 was $0.229B, a 0.3% decline from 2020.
Inspire Medical Systems Annual Share Holder Equity
(Millions of US $)
2023 $573
2022 $496
2021 $229
2020 $230
2019 $140
2018 $164
2017 $1
2016 $0
Inspire Medical Systems Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $697
2024-06-30 $638
2024-03-31 $589
2023-12-31 $573
2023-09-30 $544
2023-06-30 $529
2023-03-31 $505
2022-12-31 $496
2022-09-30 $470
2022-06-30 $227
2022-03-31 $225
2021-12-31 $229
2021-09-30 $220
2021-06-30 $220
2021-03-31 $223
2020-12-31 $230
2020-09-30 $229
2020-06-30 $234
2020-03-31 $127
2019-12-31 $140
2019-09-30 $146
2019-06-30 $152
2019-03-31 $157
2018-12-31 $164
2018-09-30 $98
2018-06-30 $103
2018-03-31 $-5
2017-12-31 $1
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.276B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00